Brachytherapy is a treatment technique in radiotherapy which consists in direct irradiation of tumour cells by placing a radiation source (radioactive element) directly in the lesion (tumour) or in its immediate vicinity.
Among the NU-MED Group centres, this method is used by the centres in Zamość, Katowice and Tomaszów Mazowiecki. An isotope of iridium (Ir-192) is applied as the radiation source.
HDR - (High Dose Rate)- refers to high dose rate and the use of a radiation source of high activity. As a result, the irradiation session lasts relatively short (usually several minutes).
With regard to radiation dose power, the following techniques are distinguished:
PROCEDURES:
What do the preparation and treatment look like?
There are two types of applications in brachytherapy treatment:
Large arrangement of applicators:
Small arrangement of applicators:
Once the applicator arrangement is in place, the medical physicist, in consultation with the doctor, prepare a treatment plan, i.e. treatment time and dose. The Patient is then treated with ionising radiation arising from the breakdown of the radiation source placed in the microSelectron HDR therapy device. During the treatment, the Patient is observed via a video camera system and an interphone system. A nurse, an electroradiology technician, a medical physicist and a radiotherapist supervise the safety of the Patient during the treatment.
How to prepare for the treatment?
What does the treatment involve?
the so-called prolapse symptoms, which may include:
The brachytherapy patient, after discharge from hospital, should contact their doctor whenever there are symptoms of concern.
In accordance with Article 32c subsection 2 of the Atomic Law Act, we hereby give notice that the activities involving exposure to ionising radiation referred to in Article 4(1) items 1, 9, 10, 11 and 16 performed in NU-MED Group centres do not adversely affect human health and the environment and do not lead to release of radioactive substances into the environment.